openPR Logo
Press release

Chronic Kidney Disease Market Expected To Surge Significantly By 2027

04-07-2022 02:18 PM CET | Health & Medicine

Press release from: Market Insights Reports

The Chronic Kidney Disease market has been thoroughly scrutinized and then carefully demarcated by geographic locations which are based on major economic regions and their topographical regions. Growing competition and the changing market dynamics have been highlighted. Aggressive market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio, and recent developments. The Chronic Kidney Disease Market share and Market size prominent players for 2022 to 2027 are profiled in this report.

The Chronic Kidney Disease Market is expected to register a CAGR of 3.9% over the forecast period 2022 - 2027.

Click the link to get a Sample Copy of the Report:

https://www.marketintelligencedata.com/reports/2344654/chronic-kidney-disease-market-growth-trends-and-forecast-2022-2027/inquiry?Mode=KD6

Competitive Landscape:

Abbott Laboratories, AbbVie Inc., Amgen Inc., Beckman Coulter, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Pfizer Inc., Siemens Healthineers, Sysmex Corporation, Teva Pharmaceutical Industries Ltd. and Others

Key Market Trends:

Blood Test Segment by Diagnosis is Expected to Witness a High Growth Over the Forecast Period

The major test for the diagnosis of kidney disease include a blood test and it helps to understand how well kidneys are working. The blood test measures levels of a waste product called creatinine in the blood. The glomerular filtration rate (eGFR) is estimated in order to understand how many milliliters of waste kidneys are able to filter in a minute.

Moreover, the demand for these tests are expected to increase as the incidence of CKD is high and growing in many parts of the world. The global prevalence of end-stage renal diseases (ESRD) is high and increasing at a significant rate. In 2017, 697á5 million cases of all-stage CKD were recorded, for a global prevalence of 9á1%, as per the Global Burden of Disease Study 2017. It is found that chronic kidney diseases (CKD) may develop over many years leading to ESRD and lead to kidney failure.

Browse the Full report description and TOC at:

https://www.marketintelligencedata.com/reports/2344654/chronic-kidney-disease-market-growth-trends-and-forecast-2022-2027?Mode=KD6

North America is Expected to Hold Largest Market Share over the Forecast Period

The United States is expected to be the largest chronic kidney disease market owing to the rising incidence of Chronic Kidney Diseases and the presence of better healthcare infrastructure. As per, the National Institute of Diabetes and Digestive and Kidney Disease, the prevalence of Chronic Kidney Disease (CKD) in the United States(US) is about 14%.

Regional Analysis for Chronic Kidney Disease Market:

North America (the United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa).

Highlights about Chronic Kidney Disease report coverage:

- A complete background analysis, which includes an assessment of the Global Chronic Kidney Disease Market.

- Important changes in Chronic Kidney Disease market dynamics

- Chronic Kidney Disease Market segmentation up to the second & third level regional bifurcation

- Historical, current, and projected size of the Chronic Kidney Disease market with respect to both value (Revenue) and volume (Production & Consumption)

- Reporting and evaluation of recent Chronic Kidney Disease industry developments

- Chronic Kidney Disease Market shares and strategies of key players

- Emerging niche Chronic Kidney Disease segments and regional markets

- An objective assessment of the trajectory of the Chronic Kidney Disease market

- Recommendations to companies for strengthening their foothold in the Chronic Kidney Disease market

The research includes historic data from 2016 to 2021 and forecasts until 2027 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

About Us:

Market intelligence data is a global front-runner in the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.

Contact Us:

Irfan Tamboli (Head of Sales) - MARKET INTELLIGENCE DATA

Phone: +1 (704) 266-3234

Mail to: sales@marketintelligencedata.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Kidney Disease Market Expected To Surge Significantly By 2027 here

News-ID: 2597686 • Views:

More Releases from Market Insights Reports

Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, Honeywell
Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, …
Market Insights Reports published a new research publication on "Cold Chain Monitoring Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cold Chain Monitoring market was mainly driven by the increasing R&D spending across the world. Some of the key players
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, Grupo Antolin
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, …
Market Insights Reports published a new research publication on "Outbound Logistics Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Outbound Logistics market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Smucker
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Sm …
Market Insights Reports published a new research publication on "Veterinary Telemedicine Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Veterinary Telemedicine market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Precision Planting Market is Set to Fly High in Years to Come
Precision Planting Market is Set to Fly High in Years to Come
Market Insights Reports published a new research publication on "Precision Planting Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Precision Planting market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and